22 Oct 2017 | 4:28 AM
 

GlaxoSmithKline Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 500660 | NSE Symbol: GLAXO
2,443.20
-0.25
(-0.01 %)
18 Oct 2017 | 03:54 PM
Change company
  • Open (Rs)
    2,450.00
  • Prev. close (Rs.)
    2,443.45
  • High (Rs.)
    2,451.00
  • Low (Rs.)
    2,420.00
  • 52W H (Rs.)
    2,999.90
  • 52W L (Rs.)
    2,309.06
  • Volume
    130
  • MCap (Rs in Cr.)
    20,694.64
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
39.76
Operating Margin (%)
13.96
Gross Profit Margin (%)
13.08
Net Profit Margin (%)
11.22
Total Debt/Equity
0.00
Dividend payout Ratio (Net Profit)
151.34
Earning Retention Ratio
-75.11

News

25 Jul 2017 - 17:17:00-GlaxoSmithKline Pharmaceuticals today reported 63...
13 Feb 2017 - 12:08:00-Pharma major GlaxoSmithKline Pharmaceuticals Ltd has reported a drop of 32...
27 Oct 2016 - 16:37:00-Drug maker GlaxoSmithKline Pharmaceuticals on Thursday reported a growth of 3...
25 May 2016 - 16:50:00-GlaxoSmithKline Pharmaceuticals a world's leading research based pharmaceutical and healthcare c...

Announcements

10-Oct-2017
GlaxoSmithKline Phar - Compliance Of Clause 40(9) Of The Listing Obligations And Disclosure Requirements Regulations 2015 (L
06-Oct-2017
GlaxoSmithKline Phar - Compliance Certificate For Half Year Ended September 2017
06-Oct-2017
GlaxoSmithKline Phar - Statement Of Investors Complaint For Quarter Ended September 2017
03-Oct-2017
GlaxoSmithKline Phar - Closure of Trading Window
03-Oct-2017
GlaxoSmithKline Phar - Trading Window

Religare Research

18 Oct 2017 | 06:00 PM
This week, we haven’t initiated fresh position and advise taking position in running recommendation....
18 Oct 2017 | 06:00 PM
Nifty managed to inch higher amid volatility, tracking favorable local cues and supportive global ...
18 Oct 2017 | 09:58 AM
The Indian rupee fell for a first time in seven sessions against the dollar, as reports U.S. Preside...
18 Oct 2017 | 09:28 AM
Gold fell on hawkish views about possible next Fed chair  Oil prices turned lower after 2-session c...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,26,413 144.86 177.16 0.02
4,26,413 144.86 709.70 0.02
4,26,413 144.86 741.51 0.02
4,26,413 144.86 251.48 0.02
4,50,000 101.80 62.09 -0.46

Shareholding Pattern

       
Promotors75.00%
Mutual Funds/UTI2.00%
FI/Banks8.55%
Insurance8.55%
FII1.77%
Government0.00%
Others1.09%

Peer Group

Company Intraday Graph
 Piramal Enterprises Ltd.
2,756.05(-0.34)
3356
 Dr. Reddy`s Laboratories Ltd.
2,384.75(0.10)
3294
 Alkem Laboratories Ltd.
1,826.05(0.01)
17141
 Torrent Pharmaceuticals Ltd.
1,384.65(4.20)
3607

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
GlaxoSmithKline Pharmaceuticals Ltd.33.65-80.15-197.55
NIFTY(S&P CNX)-6.55319.401,043.05
BSE SENSEX-33.80678.973,070.86
BSE 500-12.92572.761,510.79

Corporate Details

Key Personal
A Aristidou
WholeTime Director & CFO
A Vaidheesh
Managing Director
D S Parekh
Chairman
Key Address
Registered Office
Dr. Annie Besant Road,Mumbai,Maharashtra

Tel:022-24959595 24959415 24959434, Fax:022-24959494 24981526

askus@gsk.com
http://www.gsk-india.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda